3431-04-7

Upstream product

• 100-46-9 benzylamine 
• 907179-74-2 diethyl meso-2,6-dibromopimeloate 
• 111-16-0 heptanedioic acid 
• 182949-96-8 diethyl cis-1-methylpiperidine-2,6-dicarboxylate 
• 21495-53-4 1-methyl-piperidine-2r,6c-dicarboxylic acid dimethyl ester 

Downstream Products

• 1186532-36-4 9-methyl-3,9-diaza-bicyclo[3.3.1]nonane-3-carboxylic acid 3,4-dichloro-phenyl ester 
• 1186532-44-4 3,9-diaza-bicyclo[3.3.1]nonane-3-carboxylic acid 3,4-dichloro-phenyl ester hydrochloric acid salt 
• 3431-05-8 3-benzyl-9-methyl-3,9-diaza-bicyclo[3.3.1]nonane 

Relevant academic research and scientific papers

NOVEL 3,8-DIAZA-BICYCLO[3.2.1]OCTANE- AND 3,9-DIAZA-BICYCLO[3.3.1]-NONANE-3-CARBOXYLIC ACID ESTER DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS

This invention relates to novel 3,8-diaza-bicyclo[3.2.1]octane-and 3,9-diaza- bicyclo[3.3.1]nonane-3-carboxylic acid ester derivatives useful as monoamine neurotransmitter re-uptake inhibitors. In other aspects the invention relates to the use of these co

INDOLYL-PYRIDAZINYL-DIAZABICYCLONONANE DERIVATIVES IN LABELLED AND UNLABELLED FORM AND THEIR USE IN DIAGNOSTIC METHODS

The present invention relates to indolyl-pyhdazinyl-diazabicyclononane derivatives in their labelled and unlabelled form. Furthermore, the present invention relates to the use of said derivatives in their labelled or unlabelled form in diagnostic methods,

NOVEL DIAZABICYCLIC ARYL DERIVATIVES AND THEIR MEDICAL USE

This invention relates to novel diazabicyclic aryl derivatives, which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compounds of the invention may be useful for the treatment of diseases or disorders as diverse as those related to the cholinergic system of the central nervous system (CNS), the peripheral nervous system (PNS), diseases or disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse of chemical substances.

NOVEL DIAZABICYCLIC ARYL DERIVATIVES AND THEIR MEDICAL USE

This invention relates to novel diazabicyclic aryl derivatives which are found to be cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters. Due to their pharmacological profile the compound